LATEST NEWS AND ARTICLES

From events, scientific articles to PR, you will find here all our latest news.

Poietis Biosystems will exhibit the NGB bioprinter at TERMIS EU 2025

Poietis Biosystems' team will be present at TERMIS EU 2025 in Freiburg, Germany from 19 to 23 May. Book your live demonstration of the NGB bioprinter.

Poietis launches its new 4D Bioprinting platform

Poietis, the first 4D bioprinting company, announces the commercialization of its new range of NGB systems («Next Generation Bioprinting») to cover all the tissue engineering needs, from research to clinical batches production.

Poietis and Prometheus, division of skeletal tissue engineering of KU Leuven, enter into a Collaborative Research Agreement focused on 3D Bioprinting for skeletal ATMPs.

Poietis, leading bioprinting company and Prometheus, Division of Skeletal Tissue Engineering at KU Leuven, entered into a 2-years Collaborative Research Agreement focused on high-precision 3D Bioprinting of tissue engineered Advanced Therapeutic Medicinal Products (ATMPs) for skeletal regeneration.

Poietis closes a 5M€ financing round to accelerate the development of its bio-printing platform for tissue therapy manufacturing

Poietis, a bioprinting leader, announces that it has closed a €5 million Series A financing round to accelerate technological developments that could lead to the first implantation of a bioprinted tissue into patients from 2021.

Do you want to know more about NGB platform?